Publications

Found 2 results
Filters: Author is P. Bumrungpanichthaworn  [Clear All Filters]
2011
S. Honsawek, Deepaisarnsakul, B., Tanavalee, A., Yuktanandana, P., Bumrungpanichthaworn, P., Malila, S., and Saetan, N., Association of the IL-6 -174G/C gene polymorphism with knee osteoarthritis in a Thai population, vol. 10, pp. 1674-1680, 2011.
Banks SE (2010). Erosive osteoarthritis: a current review of a clinical challenge. Clin. Rheumatol. 29: 697-706. http://dx.doi.org/10.1007/s10067-009-1369-7 PMid:20108014 Bowcock AM, Kidd JR, Lathrop GM, Daneshvar L, et al. (1988). The human “interferon-beta 2/hepatocyte stimulating factor/interleukin-6” gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 3: 8-16. http://dx.doi.org/10.1016/0888-7543(88)90152-8 Fernández-Real JM, Broch M, Vendrell J, Richart C, et al. (2000). Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J. Clin. Endocrinol. Metab. 85: 1334-1339. http://dx.doi.org/10.1210/jc.85.3.1334 Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, et al. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102: 1369-1376. http://dx.doi.org/10.1172/JCI2629 PMid:9769329    PMCid:508984 Goldring SR and Goldring MB (2004). The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res. S27-S36. http://dx.doi.org/10.1097/01.blo.0000144854.66565.8f PMid:15480070 Ishihara K and Hirano T (2002). IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13: 357-368. http://dx.doi.org/10.1016/S1359-6101(02)00027-8 Jikko A, Wakisaka T, Iwamoto M, Hiranuma H, et al. (1998). Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures. Cell Biol. Int. 22: 615-621. http://dx.doi.org/10.1006/cbir.1998.0304 PMid:10452831 Kämäräinen OP, Solovieva S, Vehmas T, Luoma K, et al. (2008). Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res. Ther. 10: R21. Kaneko S, Satoh T, Chiba J, Ju C, et al. (2000). Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol. Ther. 6: 71-79. http://dx.doi.org/10.1080/13684730050515796 Kellgren JH and Lawrence JS (1957). Radiological assessment of osteo-arthrosis. Ann. Rheum. Dis. 16: 494-502. http://dx.doi.org/10.1136/ard.16.4.494 PMid:13498604    PMCid:1006995 Krasnokutsky S, Attur M, Palmer G, Samuels J, et al. (2008). Current concepts in the pathogenesis of osteoarthritis. Osteoarthritis Cartilage 16 (Suppl 3): S1-S3. http://dx.doi.org/10.1016/j.joca.2008.06.025 PMid:18723377 Krenn V, Hensel F, Kim HJ, Souto Carneiro MM, et al. (1999). Molecular IgV(H) analysis demonstrates highly somatic mutated B cells in synovialitis of osteoarthritis: a degenerative disease is associated with a specific, not locally generated immune response. Lab. Invest. 79: 1377-1384. PMid:10576208 Loeser RF (2009). Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage 17: 971-979. http://dx.doi.org/10.1016/j.joca.2009.03.002 PMid:19303469    PMCid:2713363 Mohtai M, Gupta MK, Donlon B, Ellison B, et al. (1996). Expression of interleukin-6 in osteoarthritic chondrocytes and effects of fluid-induced shear on this expression in normal human chondrocytes in vitro. J. Orthop. Res. 14: 67-73. http://dx.doi.org/10.1002/jor.1100140112 PMid:8618168 Pola E, Papaleo P, Pola R, Gaetani E, et al. (2005). Interleukin-6 gene polymorphism and risk of osteoarthritis of the hip: a case-control study. Osteoarthritis Cartilage 13: 1025-1028. http://dx.doi.org/10.1016/j.joca.2005.07.011 PMid:16198603 Steinmeyer J (2004). Cytokines in osteoarthritis-current status on the pharmacological intervention. Front. Biosci. 9: 575-580. http://dx.doi.org/10.2741/1253 PMid:14766392 Valdes AM, Loughlin J, Oene MV, Chapman K, et al. (2007). Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee. Arthritis Rheum. 56: 137-146. http://dx.doi.org/10.1002/art.22301
S. Honsawek, Bumrungpanichthaworn, P., Thitiset, T., and Wolfinbarger, Jr., L., Gene expression analysis of demineralized bone matrix-induced osteogenesis in human periosteal cells using cDNA array technology, vol. 10, pp. 2093-2103, 2011.
Beck GR Jr, Zerler B and Moran E (2001). Gene array analysis of osteoblast differentiation. Cell Growth Differ. 12: 61-83. PMid:11243467 Boskey AL, Spevak L, Doty SB and Rosenberg L (1997). Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif. Tissue Int. 61: 298-305. http://dx.doi.org/10.1007/s002239900339 PMid:9312200 Chen WB, Lenschow W, Tiede K, Fischer JW, et al. (2002). Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J. Biol. Chem. 277: 36118-36128. http://dx.doi.org/10.1074/jbc.M203709200 PMid:12140283 Ducy P, Schinke T and Karsenty G (2000). The osteoblast: a sophisticated fibroblast under central surveillance. Science 289: 1501-1504. http://dx.doi.org/10.1126/science.289.5484.1501 PMid:10968779 Honsawek S, Powers RM and Wolfinbarger L (2005). Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model. Cell Tissue Bank. 6: 13-23. http://dx.doi.org/10.1007/s10561-005-1445-4 PMid:15735897 Honsawek S, Dhitiseith D and Phupong V (2006). Effects of demineralized bone matrix on proliferation and osteogenic differentiation of mesenchymal stem cells from human umbilical cord. J. Med. Assoc. Thai. 89 (Suppl 3): S189-S195. PMid:17718287 Honsawek S, Dhitiseith D and Phupong V (2007). Gene expression characteristics of osteoblast differentiation in human umbilical cord mesenchymal stem cells induced by demineralized bone matrix. Asian Biomed. 1: 383-391. Honsawek S, Bumrungpanichthaworn P and Thanakit V (2010). Osteoinductive potential of small intestinal submucosa/ demineralized bone matrix as composite scaffolds for bone tissue engineering. Asian Biomed. 4: 913-922. Hutmacher DW and Sittinger M (2003). Periosteal cells in bone tissue engineering. Tissue Eng. 9 (Suppl 1): S45-S64. http://dx.doi.org/10.1089/10763270360696978 PMid:14511470 Locklin RM, Riggs BL, Hicok KC, Horton HF, et al. (2001). Assessment of gene regulation by bone morphogenetic protein 2 in human marrow stromal cells using gene array technology. J. Bone Miner. Res. 16: 2192-2204. http://dx.doi.org/10.1359/jbmr.2001.16.12.2192 PMid:11760832 Meirowitz NB, Smulian JC, Hahn RA, Zhou P, et al. (2002). Collagen messenger RNA expression in the human amniochorion in premature rupture of membranes. Am. J. Obstet. Gynecol. 187: 1679-1685. http://dx.doi.org/10.1067/mob.2002.127595 PMid:12501083 Schena M, Shalon D, Heller R, Chai A, et al. (1996). Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. U. S. A. 93: 10614-10619. http://dx.doi.org/10.1073/pnas.93.20.10614 Walchli C, Koch M, Chiquet M, Odermatt BF, et al. (1994). Tissue-specific expression of the fibril-associated collagens XII and XIV. J. Cell Sci. 107: 669-681. PMid:8207089 Wolfinbarger L Jr and Zheng Y (1993). An in vitro bioassay to assess biological activity in demineralized bone. In Vitro Cell Dev. Biol. Anim. 29A: 914-916. http://dx.doi.org/10.1007/BF02634228 Xu T, Bianco P, Fisher LW, Longenecker G, et al. (1998). Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 20: 78-82. http://dx.doi.org/10.1038/2477 PMid:9771711 Zhang M, Powers RM Jr and Wolfinbarger L Jr (1997). A quantitative assessment of osteoinductivity of human demineralized bone matrix. J. Periodontol. 68: 1076-1084. PMid:9407400